BioNexus Gene Lab Corp. Comprehensive Income
BioNexus Gene Lab Corp. (BGLC) reported Comprehensive Income of -$314.81 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-14
- BioNexus Gene Lab Corp. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was -$314.81K.
- BioNexus Gene Lab Corp. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was -$521.67K.
- BioNexus Gene Lab Corp. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was -$1.04M.
- BioNexus Gene Lab Corp. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was -$705.77K.
- BioNexus Gene Lab Corp. comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was -$2.55M.
- BioNexus Gene Lab Corp. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$1.48M.
- BioNexus Gene Lab Corp. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$2.90M.
- BioNexus Gene Lab Corp. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$664.77K, a 228.43% decline from fiscal 2021.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$314.81K 10-Q · filed 2026-08-14 | -$836.49K 10-Q · filed 2026-08-14 | -$1.88M derived: sum of 3 quarters · filed 2026-08-14 | -$2.59M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2026-03-31 | -$521.67K 10-Q · filed 2026-05-15 | -$1.57M derived: sum of 2 quarters · filed 2026-05-15 | -$2.27M derived: sum of 3 quarters · filed 2026-05-15 | -$2.52M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-12-31 | -$1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-14 | -$1.75M derived: sum of 2 quarters · filed 2026-04-14 | -$2.00M derived: sum of 3 quarters · filed 2026-08-14 | -$2.55M 10-K · filed 2026-04-14 | |||
| 2025-09-30 | -$705.77K 10-Q · filed 2025-11-14 | -$954.87K derived: sum of 2 quarters · filed 2026-08-14 | -$1.51M 10-Q · filed 2025-11-14 | -$2.57M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-06-30 | -$249.09K 10-Q · filed 2026-08-14 | -$800.26K 10-Q · filed 2026-08-14 | -$1.87M derived: sum of 3 quarters · filed 2026-08-14 | -$2.16M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-03-31 | -$551.17K 10-Q · filed 2026-05-15 | -$1.62M derived: sum of 2 quarters · filed 2026-05-15 | -$1.92M derived: sum of 3 quarters · filed 2026-05-15 | -$1.71M derived: sum of 4 quarters · filed 2026-05-15 | |||
| 2024-12-31 | -$1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-14 | -$1.36M derived: sum of 2 quarters · filed 2026-04-14 | -$1.16M derived: sum of 3 quarters · filed 2026-04-14 | -$1.48M 10-K · filed 2026-04-14 | |||
| 2024-09-30 | -$298.58K 10-Q · filed 2025-11-14 | -$97.01K derived: sum of 2 quarters · filed 2025-11-14 | -$410.68K 10-Q · filed 2025-11-14 | $21.09K derived: sum of 4 quarters · filed 2025-11-14 | |||
| 2024-06-30 | $201.57K 10-Q · filed 2025-08-18 | -$112.10K 10-Q · filed 2025-08-18 | $319.67K derived: sum of 3 quarters · filed 2025-08-18 | -$2.31M derived: sum of 4 quarters · filed 2025-08-18 | |||
| 2024-03-31 | -$313.67K 10-Q · filed 2025-05-15 | $118.10K derived: sum of 2 quarters · filed 2025-05-15 | -$2.51M derived: sum of 3 quarters · filed 2025-05-15 | -$3.10M derived: sum of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | $431.76K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | -$2.20M derived: sum of 2 quarters · filed 2025-04-15 | -$2.79M derived: sum of 3 quarters · filed 2025-04-15 | -$2.90M 10-K · filed 2025-04-15 | |||
| 2023-09-30 | -$2.63M 10-Q · filed 2024-11-15 | -$3.22M derived: sum of 2 quarters · filed 2024-11-15 | -$3.33M 10-Q · filed 2024-11-15 | -$3.09M derived: sum of 4 quarters · filed 2024-11-15 | |||
| 2023-06-30 | -$593.14K 10-Q · filed 2024-08-14 | -$701.25K 10-Q · filed 2024-08-14 | -$459.89K derived: sum of 3 quarters · filed 2024-08-14 | -$857.88K derived: sum of 4 quarters · filed 2024-08-14 | |||
| 2023-03-31 | -$108.11K 10-Q · filed 2024-05-15 | $133.25K derived: sum of 2 quarters · filed 2024-05-15 | -$264.74K derived: sum of 3 quarters · filed 2024-05-15 | -$721.16K derived: sum of 4 quarters · filed 2024-05-15 | |||
| 2022-12-31 | $241.36K derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-04-16 | -$156.63K derived: sum of 2 quarters · filed 2024-04-16 | -$613.06K derived: sum of 3 quarters · filed 2024-04-16 | -$664.77K 10-K · filed 2024-04-16 | |||
| 2022-09-30 | -$397.99K 10-Q/A · filed 2024-03-26 | -$854.41K derived: sum of 2 quarters · filed 2024-03-26 | -$906.13K 10-Q/A · filed 2024-03-26 | -$777.95K derived: sum of 4 quarters · filed 2024-03-26 | |||
| 2022-06-30 | -$456.42K 10-Q · filed 2023-08-16 | -$508.13K 10-Q · filed 2023-08-16 | -$379.96K derived: sum of 3 quarters · filed 2023-08-16 | -$141.58K derived: sum of 4 quarters · filed 2023-08-16 | |||
| 2022-03-31 | -$51.71K 10-Q · filed 2023-05-09 | $76.46K derived: sum of 2 quarters · filed 2023-05-09 | $314.85K derived: sum of 3 quarters · filed 2023-05-09 | $335.64K derived: sum of 4 quarters · filed 2023-05-09 | |||
| 2021-12-31 | $128.17K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $366.56K derived: sum of 2 quarters · filed 2023-03-31 | $387.35K derived: sum of 3 quarters · filed 2023-03-31 | $517.63K 10-K · filed 2023-03-31 | |||
| 2021-09-30 | $238.38K 10-Q · filed 2022-11-14 | $259.18K derived: sum of 2 quarters · filed 2022-11-14 | $389.45K 10-Q · filed 2022-11-14 | $369.14K derived: sum of 4 quarters · filed 2022-11-14 | |||
| 2021-06-30 | $20.79K 10-Q · filed 2022-08-15 | $151.07K 10-Q · filed 2022-08-15 | $130.76K derived: sum of 3 quarters · filed 2022-08-15 | $613.29K derived: sum of 4 quarters · filed 2022-08-15 | |||
| 2021-03-31 | $130.28K 10-Q · filed 2022-05-16 | $109.97K derived: sum of 2 quarters · filed 2022-05-16 | $592.50K derived: sum of 3 quarters · filed 2022-05-16 | $600.21K derived: sum of 4 quarters · filed 2022-05-16 | |||
| 2020-12-31 | -$20.31K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-06 | $462.22K derived: sum of 2 quarters · filed 2022-04-06 | $469.94K derived: sum of 3 quarters · filed 2022-04-06 | $1.24M 10-K · filed 2022-04-06 | |||
| 2020-09-30 | $482.53K 10-Q · filed 2021-11-15 | -$38.09K 10-Q · filed 2020-11-03 | $490.25K derived: sum of 2 quarters · filed 2021-11-15 | $1.27M 10-Q · filed 2021-11-15 | -$190.77K 10-Q · filed 2020-11-03 | $1.19M derived: sum of 4 quarters · filed 2021-11-15 | |
| 2020-06-30 | $7.72K 10-Q · filed 2021-08-12 | -$63.05K 10-Q · filed 2020-08-11 | $782.66K 10-Q · filed 2021-08-12 | -$152.68K 10-Q · filed 2020-08-11 | $711.22K derived: sum of 3 quarters · filed 2021-08-12 | $678.39K derived: sum of 4 quarters · filed 2021-08-12 | |
| 2020-03-31 | $774.95K 10-Q · filed 2021-05-18 | -$89.63K 10-Q · filed 2020-05-08 | $703.50K derived: sum of 2 quarters · filed 2021-05-18 | $670.67K derived: sum of 3 quarters · filed 2021-05-18 | $582.67K derived: sum of 4 quarters · filed 2021-05-18 | ||
| 2019-12-31 | -$71.45K derived: 10-K 12 month − 10-Q/A 9 month · filed 2021-03-30 | -$104.28K derived: sum of 2 quarters · filed 2021-03-30 | -$192.28K derived: sum of 3 quarters · filed 2021-03-30 | -$236.59K 10-K · filed 2021-03-30 | |||
| 2019-09-30 | -$32.83K 10-Q/A · filed 2020-11-09 | -$120.83K derived: sum of 2 quarters · filed 2020-11-09 | -$165.15K 10-Q/A · filed 2020-11-09 | -$262.90K derived: sum of 4 quarters · filed 2020-11-09 | |||
| 2019-06-30 | -$88.00K 10-Q · filed 2020-08-11 | -$72.42K 10-Q · filed 2019-08-09 | -$132.32K 10-Q · filed 2020-08-11 | -$230.07K derived: sum of 3 quarters · filed 2020-08-11 | -$312.60K derived: sum of 4 quarters · filed 2020-08-11 | ||
| 2019-03-31 | -$44.32K 10-Q · filed 2020-05-08 | -$44.50K 10-Q · filed 2019-05-15 | -$142.08K derived: sum of 2 quarters · filed 2020-05-08 | -$224.60K derived: sum of 3 quarters · filed 2020-05-08 | -$278.52K derived: sum of 4 quarters · filed 2020-05-08 | ||
| 2018-12-31 | -$97.75K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-31 | -$180.28K derived: sum of 2 quarters · filed 2020-03-31 | -$234.20K derived: sum of 3 quarters · filed 2020-03-31 | -$14.57K 10-K · filed 2020-03-31 | |||
| 2018-09-30 | -$82.53K 10-Q · filed 2019-11-14 | -$136.44K derived: sum of 2 quarters · filed 2019-11-14 | $83.18K 10-Q · filed 2019-11-14 | ||||
| 2018-06-30 | -$53.92K 10-Q · filed 2019-08-09 | $165.70K 10-Q · filed 2019-08-09 | |||||
| 2018-03-31 | $273.61K 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |